Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
silymarin (1 trial)
Fatty Liver (Phase 4)
Liver Diseases (Phase 4)
Non-alcoholic Fatty Liver Disease (Phase 4)
Trials (1 total)
Trial APIs (1 total)